Valuation: Adocia

Market Cap 41.99M 47.26M 39.19M 35.72M 67.37M 4.54B 67.99M 474M 184M 2.32B 177M 174M 7.45B P/E 2026 *
-2.62x
P/E 2027 * 3.1x
Enterprise Value 46.39M 52.21M 43.3M 39.46M 74.43M 5.02B 75.12M 524M 203M 2.57B 196M 192M 8.23B EV / Sales 2026 *
-
EV / Sales 2027 * 1.61x
Free-Float
93.92%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 55 11/05/2023
Director of Finance/CFO - 23/09/2024
Chief Tech/Sci/R&D Officer - 01/12/2014
Director TitleAgeSince
Director/Board Member 55 19/04/2013
Chairman 57 -
Director/Board Member 61 11/05/2023
Change 5-day change 1-year change 3-year change Capi.($)
-5.93%-12.50% - - 47.26M
+4.16%+3.04%+49.37%+94.17% 74.16B
-3.11%-3.53%+21.92%+74.60% 57.39B
+0.89%-0.63%+4.28%+34.51% 47.64B
+0.36%+0.81%+352.17%+689.61% 44.29B
-0.96%-4.50%+26.36%+33.18% 42.5B
-0.20%-0.77%+3.74%+100.60% 40.71B
-0.54%+2.93%+9.31%+50.41% 30.97B
-2.68%+2.92%+29.63%+19.50% 28.53B
+0.05%-1.64%-7.28%-14.06% 24.34B
Average -0.80%-0.59%+54.39%+120.28% 43.39B
Weighted average by Cap. +0.12%-0.84%+58.77%+129.91%

Financials

2026 *2027 *
Net sales - 44.87M 50.5M 41.88M 38.17M 71.99M 4.85B 72.66M 507M 196M 2.48B 190M 185M 7.96B
Net income -16M -18.01M -14.93M -13.61M -25.67M -1.73B -25.91M -181M -70.03M -885M -67.61M -66.14M -2.84B -44.33M -49.89M -41.37M -37.71M -71.12M -4.8B -71.78M -501M -194M -2.45B -187M -183M -7.87B
Net Debt 4.4M 4.95M 4.11M 3.74M 7.06M 476M 7.13M 49.7M 19.26M 243M 18.59M 18.19M 781M 30.18M 33.96M 28.16M 25.67M 48.42M 3.26B 48.87M 341M 132M 1.67B 128M 125M 5.36B
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
73
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-